✦ LIBER ✦

Safety, efficacy, tolerability, and pharmacokinetics of a new liquid intravenous immunoglobulin (IVIG) in comparison to Sandoglobulin® in patients with primary immunodeficiencies (PID)

✍ Scribed by Borte, M.; Wahn, U.; Farber, C.; Bernatowska, E.; Adams, C.; Andresen, I.; Bender, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Efficacy and Pharmacokinetics of

✍ Wasserman, Richard L.; Church, Joseph A.; Stein, Mark; Moy, James; White, Martha 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 154 KB

Safety and Efficacy of Privigen®, a Nove

✍ Mark R. Stein; Robert P. Nelson; Joseph A. Church; Richard L. Wasserman; Michael 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB

Efficacy, Pharmacokinetics, Safety, and

✍ Melvin Berger; Paul J. Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

A 10% liquid immunoglobulin preparation

✍ Lozano-Blasco, J.; Martín-Mateos, M.A.; Alsina, L.; Domínguez, O.; Giner, M.T.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Efficacy, Safety and Tolerability of a N

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB

Efficacy, safety and tolerability of a n

✍ Church, J.A.; Leibl, H.; Stein, M.R.; Melamed, I.R.; Rubinstein, A.; Schneider, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 26 KB